Inhalers & Respiratory
18 drugs in this class, prescribed by 626,206 Medicare Part D providers.
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$5.73B
Total Cost
27,538,514
Claims
18
Drugs
$208
Avg Cost/Claim
Key Insights
- Most expensive per prescription: Trelegy Ellipta at $885/claim
- Most prescribed: Albuterol Sulfate Hfa with 7,904,120 claims
- This class represents 2.1% of total Medicare Part D spending
All Inhalers & Respiratory Drugs
| Drug | Cost | Claims |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | $1.81B | 2,046,216 |
| Budesonide/Formoterol Fumarate | $759.4M | 1,452,561 |
| Fluticasone Propion/Salmeterol | $523.2M | 1,289,942 |
| Fluticasone/Vilanterol | $493.0M | 909,837 |
| Tiotropium Bromide | $478.1M | 673,800 |
| Albuterol Sulfate | $312.2M | 7,904,120 |
| Umeclidinium Brm/Vilanterol Tr | $294.3M | 480,651 |
| Budesonide/Glycopyr/Formoterol | $280.9M | 340,138 |
| Fluticasone Propionate | $187.5M | 5,343,836 |
| Umeclidinium Bromide | $131.6M | 290,677 |
| Tiotropium Br/Olodaterol Hcl | $130.3M | 201,233 |
| Ipratropium/Albuterol Sulfate | $108.3M | 353,594 |
| Montelukast Sodium | $81.3M | 5,086,706 |
| Ipratropium Bromide | $45.4M | 656,249 |
| Budesonide | $33.1M | 120,202 |
| Fluticasone Furoate | $23.7M | 74,825 |
| Mometasone/Formoterol | $20.4M | 46,961 |
| Mometasone Furoate | $14.7M | 266,966 |